Publications

2024

Enterovirus A71 crosses a human blood-brain barrier model through infected immune cells.

Gaume L, Chabrolles H, Bisseux M, Lopez-Coqueiro I, Dehouck L, Mirand A, Henquell C, Gosselet F, Archimbaud C, Bailly J-L.

Microbiol Spectr. 2024 May 16:e0069024.

doi: 10.1128/spectrum.00690-24.

PMID: 38752731

DOI : 10.1128/spectrum.00690-24

Synergistic induction of blood-brain barrier properties.

Porkoláb G, Mészáros M, Szecskó A, Vigh JP, Walter FR, Figueiredo R, Kálomista I, Hoyk Z, Vizsnyiczai G, Gróf I, Jan JS, Gosselet F, Pirity MK, Vastag M, Hudson N, Campbell M, Veszelka S, Deli MA.

Proc Natl Acad Sci U S A. 2024 May 21;121(21):e2316006121.

PMID: 38748577

DOI: 10.1073/pnas.2316006121.

Evaluation of the impact of iPSC differentiation protocols on transcriptomic signatures.

Chandrasekaran V, Wellens S, Bourguignon A, Djidrovski I, Fransen L, Ghosh S, Mazidi Z, Murphy C, Nunes C, Singh P, Zana M, Armstrong L, Dinnyés A, Grillari J, Grillari-Voglauer R, Leonard MO, Verfaillie C, Wilmes A, Zurich MG, Exner T, Jennings P, Culot M.

Toxicol In Vitro. 2024 Apr 12:105826.

PMID: 38615723

DOI: 10.1016/j.tiv.2024.105826.

Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches.

Welsh JA, and MISEV Consortium.

J Extracell Vesicles. 2024 Feb;13(2):e12404.

PMID: 38326288

DOI: 10.1002/jev2.12404.

Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.

Masloh S, Chevrel A, Culot M, Perrocheau A, Kalia YN, Frehel S, Gaussin R, Gosselet F, Huet S, Zeisser Labouebe M, Scapozza L.

Pharmaceutics. 2024 Jan 16;16(1):116.

PMID: 38258126

DOI: 10.3390/pharmaceutics16010116.